![](/img/cover-not-exists.png)
P2.01-22 ORCHARD: A Phase II Platform Study in Patients with Advanced NSCLC Who Have Progressed on First-Line Osimertinib Therapy
Yu, H., Goldberg, S., Le, X., Piotrowska, Z., Smith, P., Mensi, I., Kirova, B., Chmielecki, J., Li-Sucholeicki, X., Szekeres, P., Doughton, G., Patel, G., Jewsbury, P., Riess, J.Volume:
14
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2019.08.1366
Date:
October, 2019
File:
PDF, 249 KB
2019